311 related articles for article (PubMed ID: 29329618)
1. Vaccination against Fasciola hepatica using cathepsin L3 and B3 proteases delivered alone or in combination.
Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
Vet Parasitol; 2018 Jan; 250():15-21. PubMed ID: 29329618
[TBL] [Abstract][Full Text] [Related]
2. Sex and vaccination: Insights from female rats vaccinated with juvenile-specific proteases from Fasciola hepatica.
Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
Vet Parasitol; 2018 May; 255():91-96. PubMed ID: 29773143
[TBL] [Abstract][Full Text] [Related]
3. Vaccination against fasciolosis by a multivalent vaccine of stage-specific antigens.
Jayaraj R; Piedrafita D; Dynon K; Grams R; Spithill TW; Smooker PM
Vet Parasitol; 2009 Mar; 160(3-4):230-6. PubMed ID: 19081192
[TBL] [Abstract][Full Text] [Related]
4. Characterization and differential expression of cathepsin L3 alleles from Fasciola hepatica.
Zawistowska-Deniziak A; Wasyl K; Norbury LJ; Wesołowska A; Bień J; Grodzik M; Wiśniewski M; Bąska P; Wędrychowicz H
Mol Biochem Parasitol; 2013 Jul; 190(1):27-37. PubMed ID: 23770026
[TBL] [Abstract][Full Text] [Related]
5. Intranasal delivery of a formulation containing stage-specific recombinant proteins of Fasciola hepatica cathepsin L5 and cathepsin B2 triggers an anti-fecundity effect and an adjuvant-mediated reduction in fluke burden in sheep.
Norbury LJ; Basałaj K; Zawistowska-Deniziak A; Sielicka A; Wilkowski P; Wesołowska A; Smooker PM; Wędrychowicz H
Vet Parasitol; 2018 Jul; 258():14-23. PubMed ID: 30105973
[TBL] [Abstract][Full Text] [Related]
6. Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and/or vaccinated cattle and identification of protective linear B-cell epitopes.
Garza-Cuartero L; Geurden T; Mahan SM; Hardham JM; Dalton JP; Mulcahy G
Vaccine; 2018 Feb; 36(7):958-968. PubMed ID: 29373193
[TBL] [Abstract][Full Text] [Related]
7. Phage display-based vaccine with cathepsin L and excretory-secretory products mimotopes of Fasciola hepatica induces protective cellular and humoral immune responses in sheep.
Villa-Mancera A; Olivares-Pérez J; Olmedo-Juárez A; Reynoso-Palomar A
Vet Parasitol; 2021 Jan; 289():109340. PubMed ID: 33373968
[TBL] [Abstract][Full Text] [Related]
8. Identification of protective peptides of Fasciola hepatica-derived cathepsin L1 (FhCL1) in vaccinated sheep by a linear B-cell epitope mapping approach.
Buffoni L; Garza-Cuartero L; Pérez-Caballero R; Zafra R; Javier Martínez-Moreno F; Molina-Hernández V; Pérez J; Martínez-Moreno Á; Mulcahy G
Parasit Vectors; 2020 Jul; 13(1):390. PubMed ID: 32736582
[TBL] [Abstract][Full Text] [Related]
9. Vaccination with cathepsin L phage-exposed mimotopes, single or in combination, reduce size, fluke burden, egg production and viability in sheep experimentally infected with Fasciola hepatica.
Villa-Mancera A; Alcalá-Canto Y; Reynoso-Palomar A; Olmedo-Juárez A; Olivares-Pérez J
Parasitol Int; 2021 Aug; 83():102355. PubMed ID: 33872793
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel Fasciola hepatica cathepsin L protease containing protective epitopes within the propeptide.
Harmsen MM; Cornelissen JB; Buijs HE; Boersma WJ; Jeurissen SH; van Milligen FJ
Int J Parasitol; 2004 May; 34(6):675-82. PubMed ID: 15111089
[TBL] [Abstract][Full Text] [Related]
11. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica.
Mulcahy G; O'Connor F; McGonigle S; Dowd A; Clery DG; Andrews SJ; Dalton JP
Vaccine; 1998; 16(9-10):932-9. PubMed ID: 9682340
[TBL] [Abstract][Full Text] [Related]
12. Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines.
Dalton JP; Neill SO; Stack C; Collins P; Walshe A; Sekiya M; Doyle S; Mulcahy G; Hoyle D; Khaznadji E; Moiré N; Brennan G; Mousley A; Kreshchenko N; Maule AG; Donnelly SM
Int J Parasitol; 2003 Sep; 33(11):1173-81. PubMed ID: 13678633
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the Fasciola hepatica newly excysted juvenile cathepsin L3 (FhCL3) by its propeptide: a proposed 'clamp-like' mechanism of binding and inhibition.
Pritsch IC; Tikhonova IG; Jewhurst HL; Drysdale O; Cwiklinski K; Molento MB; Dalton JP; Verissimo CM
BMC Mol Cell Biol; 2020 Dec; 21(1):90. PubMed ID: 33287692
[TBL] [Abstract][Full Text] [Related]
14. Vaccine potential of recombinant pro- and mature cathepsinL1 against fasciolosis gigantica in mice.
Kueakhai P; Changklungmoa N; Chaichanasak P; Jaikua W; Itagaki T; Sobhon P
Acta Trop; 2015 Oct; 150():71-8. PubMed ID: 26116785
[TBL] [Abstract][Full Text] [Related]
15. Protection of cattle against a natural infection of Fasciola hepatica by vaccination with recombinant cathepsin L1 (rFhCL1).
Golden O; Flynn RJ; Read C; Sekiya M; Donnelly SM; Stack C; Dalton JP; Mulcahy G
Vaccine; 2010 Aug; 28(34):5551-7. PubMed ID: 20600503
[TBL] [Abstract][Full Text] [Related]
16. Cathepsin L proteinases as vaccines against infection with Fasciola hepatica (liver fluke) in ruminants.
Mulcahy G; Dalton JP
Res Vet Sci; 2001 Feb; 70(1):83-6. PubMed ID: 11170858
[TBL] [Abstract][Full Text] [Related]
17. The major cathepsin L secreted by the invasive juvenile Fasciola hepatica prefers proline in the S2 subsite and can cleave collagen.
Corvo I; Cancela M; Cappetta M; Pi-Denis N; Tort JF; Roche L
Mol Biochem Parasitol; 2009 Sep; 167(1):41-7. PubMed ID: 19383516
[TBL] [Abstract][Full Text] [Related]
18. Juvenile-specific cathepsin proteases in Fasciola spp.: their characteristics and vaccine efficacies.
Meemon K; Sobhon P
Parasitol Res; 2015 Aug; 114(8):2807-13. PubMed ID: 26099239
[TBL] [Abstract][Full Text] [Related]
19. Proteolytic activity in Fasciola hepatica is reduced by the administration of cathepsin L mimotopes.
Villa-Mancera A; Quiroz-Romero H; Correa D; Alonso RA
J Helminthol; 2011 Mar; 85(1):51-5. PubMed ID: 20416126
[TBL] [Abstract][Full Text] [Related]
20. Cloning and expression of the major secreted cathepsin B-like protein from juvenile Fasciola hepatica and analysis of immunogenicity following liver fluke infection.
Law RH; Smooker PM; Irving JA; Piedrafita D; Ponting R; Kennedy NJ; Whisstock JC; Pike RN; Spithill TW
Infect Immun; 2003 Dec; 71(12):6921-32. PubMed ID: 14638781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
